Similar articles

• Does agomelatine block 5-HT2C receptors in humans?

  Sharpley AL, Rawlings NB, Brain S, McTavish SF, Cowen PJ. Sharpley AL, et al. Psychopharmacology (Berl). 2011 Feb;213(2-3):653-5. doi: 10.1007/s00213-010-1993-6. Epub 2010 Aug 21. Psychopharmacology (Berl). 2011. PMID: 20730417 Clinical Trial. No abstract available.
• Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.

  Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N. Harada K, et al. Eur J Pharmacol. 2006 Dec 28;553(1-3):171-84. doi: 10.1016/j.ejphar.2006.09.042. Epub 2006 Sep 28. Eur J Pharmacol. 2006. PMID: 17074317
• Homology modelling of the serotoninergic 5-HT2c receptor.

  Farce A, Dilly S, Yous S, Berthelot P, Chavatte P. Farce A, et al. J Enzyme Inhib Med Chem. 2006 Jun;21(3):285-92. doi: 10.1080/14756360600700608. J Enzyme Inhib Med Chem. 2006. PMID: 16918076
• Diltiazem potentiates pentobarbital-induced hypnosis via 5-HT1A and 5-HT2A/2C receptors: role for dorsal raphe nucleus.

  Cui SY, Cui XY, Zhang J, Wang ZJ, Yu B, Sheng ZF, Zhang XQ, Shi XL, Zhang YH. Cui SY, et al. Pharmacol Biochem Behav. 2011 Oct;99(4):566-72. doi: 10.1016/j.pbb.2011.06.001. Epub 2011 Jun 12. Pharmacol Biochem Behav. 2011. PMID: 21689675
• The new Z-drugs as sedatives and hypnotics.

  Wynn RL, Bergman SA. Wynn RL, et al. Gen Dent. 2005 May-Jun;53(3):174-7. Gen Dent. 2005. PMID: 15960472 Review. No abstract available.